An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Gardiner Harris Science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
  • Dr. Carolyn Hendricks A medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard Former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Dr. Peter Bach Attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Untangling The Lies Of Rep. George Santos

Thursday, Jan 19 2023Behind the lies of Congressman George Santos. Diane talks to the owner of the small weekly paper that first broke the story, and a Washington Post journalist who is following the money to see who financed Santos's political rise.